Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: J Burn Care Res. 2014 Mar-Apr;35(2):e83–e92. doi: 10.1097/BCR.0b013e31828a8d6e

Fig. 5. Topical p38 MAPK inhibition attenuates dermal IL-6 mRNA expression.

Fig. 5

RT-qPCR results demonstrated significant reduction of dermal IL-6 mRNA expression for treatment vs. untreated burn control. mRNA was isolated from skin at 24 h post-injury. Data are represented as mean ± 95% confidence interval. *P< 0.001, ANOVA, n= 10 per group (5 animals/group × 2 experiments).